Ora Launches Clinical Intelligence Committee, Bringing Collective KOL Guidance to Ophthalmic Research
Ora, the world's leading ophthalmic clinical research organization, today announced the launch of the Ora Clinical Intelligence Committee (CIC), a new global network of distinguished ophthalmic experts created to help innovators make smarter, more confident development program decisions. Building on Ora's decades of ophthalmology-focused development expertise, the Ora CIC provides innovators with a structured and practical way to access expert guidance on the clinical, operational, and regulatory questions that shape successful development programs. The CIC is designed to help innovators pressure-test critical decisions, challenge assumptions, and strengthen development strategies through collaboration with world-renowned specialists across ophthalmology.
Bridging Clinical Practice and Drug Development, Ora Appoints Dr. John Trein as Therapeutic Lead, Posterior
Ora, the world's leading ophthalmic contract research organization and product development firm, today announced the appointment of João (John) Trein, MD, MpH, as Therapeutic Lead, Posterior, further strengthening the company's leadership in retinal disease and posterior segment drug development.
Ora Unveils Breakthrough Research in Ophthalmic Clinical Trials, New Blind Canvas Project Stories at ARVO 2026
Ora, the leading global ophthalmic contract research organization (CRO), today announced the presentation of new scientific research at the Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting, taking place May 3–7 in Denver, Colorado.
Ora Appoints Industry Veteran Bill Sharbaugh as Chairman of the Board of Directors
Ora, the leading global ophthalmic contract research organization (CRO), today announced the appointment of pharmaceutical industry veteran Bill Sharbaugh as Chairman of its Board of Directors. The appointment represents a strategic addition to Ora’s leadership as the company scales its ophthalmic clinical research capabilities.
Ora Strengthens Global Client Experience with Appointment of Henry Gerock III as General Counsel
Ora, the leading global ophthalmic contract research organization (CRO), is pleased to announce the appointment of Henry (Hank) Gerock III as General Counsel.
Ora Unveils Breakthrough Clinical Trial Innovations at ARVO 2025
Ora, the leading global ophthalmology contract research organization (CRO), is pleased to announce our participation in the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting (May 4-8) in Salt Lake City, Utah.
Ora Strengthens Commitment to Delight Customers with New CCO
Ora, the leading global ophthalmic contract research organization (CRO), is pleased to announce the appointment of Cindy Markham as Chief Commercial Officer. This new commercial leadership, along with investments in data management and human resources, will advance how Ora ensures a customer experience unsurpassed by other Ophthalmic CROs.
Ora & BlindCAN Evolve Purpose-Driven Initiative, The Blind Canvas Project, in Collaboration With Academy of Music for the Blind
Ora, the global leader in ophthalmology clinical research, alongside BlindCAN, a nonprofit foundation highlighting the unique stories of the blind community, is proud to announce the next chapter of its groundbreaking initiative the Blind Canvas Project, featuring new work created in collaboration with the Academy of Music for the Blind (AMB). Originally launched in late 2023, The Blind Canvas Project was designed to amplify the voices and perspectives of individuals who are blind or visually impaired. By showcasing their unique experiences, the initiative fosters empathy and understanding and celebrates the diverse ways in which people engage with the world around them.
Ora Strengthens Global Leadership with Key Appointments in Europe and People Services
Ora, the leading global ophthalmic contract research organization (CRO), is pleased to announce the appointments of Marcin Ernst, MD, MBA, as Vice President of Europe, and Tim Neathery as Chief People Officer. These strategic additions come as Ora intensifies its commitment to scaling global operations and attracting top talent to deliver unparalleled services to ophthalmic innovators worldwide.
Ora Partners with the Institute of Eye Surgery to Accelerate Patient Access to Cutting-Edge Ophthalmology Treatments
Ora, the leading global ophthalmic contract research organisation (CRO), announced today its partnership with Institute of Eye Surgery, Ireland’s largest private ophthalmology service provider known for its innovation, excellence, and expertise in eye care.
Ora Announces Strategic Investment from The Vistria Group to Propel Global Growth, Enhance Customer Experience in Ophthalmic Research
Ora, the leading global ophthalmic contract research organization (CRO), is excited to announce that it has been recapitalized by The Vistria Group, a middle-market private investment firm that seeks to deliver both financial returns and societal impact.
Introducing Ora, a Revolutionary New Approach to Dental Practice Management
Meet Ora, the first-of-its-kind to deliver on the promise of providing “all-in-one” practice management software to dental practices. Ora revolutionizes operations for dental practices and DSOs, providing a comprehensive suite of tools integrated to create a truly unified experience — one platform, one support team, one login, one bill.
